Raju Prasad - Net Worth and Insider Trading
Raju Prasad Net Worth
The estimated net worth of Raju Prasad is at least $360,389 dollars as of 2024-05-14. Raju Prasad is the CFO of CRISPR Therapeutics AG and owns about 6,476 shares of CRISPR Therapeutics AG (CRSP) stock worth over $360,389. Details can be seen in Raju Prasad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raju Prasad has not made any transactions after 2024-03-15 and currently still holds the listed stock(s).
Transaction Summary of Raju Prasad
Raju Prasad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raju Prasad owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of Raju Prasad’s form 4 insider trades.
Insider Ownership Summary of Raju Prasad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2024-03-15 | Chief Financial Officer |
Raju Prasad Latest Holdings Summary
Raju Prasad currently owns a total of 1 stock. Raju Prasad owns 6,476 shares of CRISPR Therapeutics AG (CRSP) as of March 15, 2024, with a value of $360,389.
Latest Holdings of Raju Prasad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2024-03-15 | 6,476 | 55.65 | 360,389 |
Holding Weightings of Raju Prasad
Raju Prasad Form 4 Trading Tracker
According to the SEC Form 4 filings, Raju Prasad has made a total of 1 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 3,524 shares on March 15, 2024, which brought Raju Prasad around $256,160.
Insider Trading History of Raju Prasad
- 1
Raju Prasad Trading Performance
Raju Prasad Ownership Network
Raju Prasad Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Raju Prasad is the Chief Financial Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , General Counsel and Secretary James R. Kasinger , and Chief Medical Officer Phuong Khanh Morrow .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Raju Prasad made 1 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 3,524. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 325,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger ,
In summary, during the past 3 months, insiders sold 89,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 89,721 shares. During the past 18 months, 334,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 334,721 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Raju Prasad Mailing Address
Above is the net worth, insider trading, and ownership report for Raju Prasad. You might contact Raju Prasad via mailing address: Crispr Therapeutics, Inc., 105 W First Street, Boston Ma 02127.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
